CareLit · DOI-Nachweis · Klinische Pädiatrie
Epigenetic profiling identifies MIR10A-5 p as a putative tumor suppresor in Ewing sarcoma and rhabdomyosarcoma
DOI 10.1055/s-0036-1582504
Bibliografische Angaben
Nachweis in CareLit
Autor:innenDH Martín, F Court, S Rello-Varona, M Sáinz-Jaspeado, R Buj, S Morán, S García-Monclús, J Huertas-Martínez, J Mora, MA Peinado, J Alonso, E de Álava, M Esteller, OM Tirado
ZeitschriftKlinische Pädiatrie
Ausgabe05/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Aberrant DNA methylation is thought to be closely related to the development of cancer. Therefore, the identification of specific DNA methylation markers in Ewing sarcoma (ES) and Rhabdomyosarcoma (RMS) would be helpful for understanding the pathogenetic mechanism as well as for developing new therapies. We analyzed the methylome of ES and RMS tumors and cell lines. Methods: Infinium 450k Illumina meth…
Zitieren
Zitierempfehlung
DH Martín, F Court, S Rello-Varona, M Sáinz-Jaspeado, R Buj, S Morán, S García-Monclús, J Huertas-Martínez, J Mora, MA Peinado, J Alonso, E de Álava, M Esteller, OM Tirado (2016) Epigenetic profiling identifies MIR10A-5 p as a putative tumor suppresor in Ewing sarcoma and rhabdomyosarcoma. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0036-1582504
Mit CareLit weiterarbeiten